Shen, L., Shah, B. R, Reyes, E. M, Thomas, L., Wojdyla, D., Diem, P., Leiter, L. A, Charbonnel, B., Mareev, V., Horton, E. S, Haffner, S. M, Soska, V., Holman, R., Bethel, M. A, Schaper, F., Sun, J. L, McMurray, J. J, Califf, R. M & Krum, H. (2013). Role of diuretics, ß blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ,347 1-10. United Kingdom: B M J Group. Retrieved from https://doi.org/10.1136/bmj.f6745
Objective: To examine the degree to which use of β blockers, statins, and diuretics in patients with impaired glucose tolerance and other cardiovascular risk factors is associated with new onset diabetes. Design Reanalysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Mary MacKillop Institute for Health Research
Open Access Journal Article
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License